Vaxxinity, Inc.
VAXX · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $108 | $174 | $319 | $286 |
| - Cash | $5 | $17 | $37 | $23 |
| + Debt | $15 | $13 | $14 | $14 |
| Enterprise Value | $118 | $170 | $295 | $278 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$1 | -$1 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$12 | -$13 | -$18 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$13 | -$14 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.09 | -0.1 | -0.11 | -0.15 |
| % Growth | 10.1% | 9.1% | 26.7% | – |
| Operating Cash Flow | -$12 | -$13 | -$12 | -$20 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$12 | -$13 | -$12 | -$20 |